Li-Chung Ma

Title: The Innovative Contributions of Li-Chung Ma

Introduction

Li-Chung Ma is a prominent inventor based in Princeton Junction, NJ (US). He has made significant contributions to the field of virology, particularly in the development of vaccines and inhibitors for the influenza A virus. With a total of 3 patents, his work has the potential to impact public health significantly.

Latest Patents

Li-Chung Ma's latest patents focus on influenza A virus vaccines and inhibitors. The inventions include compositions and methods related to the structure and function of the cellular polyadenylation and specificity factor 30 (CPSF30) binding site on the surface of the influenza A non-structural protein 1 (NS1). These patents describe critical biochemical reagents, conditions for crystallization and NMR analysis, assays, and general processes for discovering, designing, and optimizing small molecule inhibitors of influenza A (avian flu) viruses. Additionally, they outline methods for creating attenuated influenza virus strains suitable for avian and human flu vaccine development.

Career Highlights

Throughout his career, Li-Chung Ma has worked with esteemed institutions such as the University of Texas System and Rutgers, the State University of New Jersey. His research has been pivotal in advancing the understanding of influenza viruses and developing effective treatments and vaccines.

Collaborations

Li-Chung Ma has collaborated with notable colleagues, including Gaetano T Montelione and Kalyan Das. These partnerships have contributed to the success of his research and innovations in the field.

Conclusion

Li-Chung Ma's work exemplifies the importance of innovation in addressing global health challenges. His contributions to influenza A virus research are invaluable and continue to pave the way for future advancements in vaccine development.